Review
Open access
Sep 2026
Daratumumab Treatment in Severe Anti-NMDAR Encephalitis
Objectives To describe clinical outcomes following daratumumab therapy in severe anti–N-methyl-d-aspartate receptor (NMDAR) encephalitis, including a literature review. Methods We report 2 patients with severe anti-NMDAR encephalitis treated with anti-CD38 daratumumab after failure of multiple immunotherapies. Clinical...
Nady Ammar, Marjolaine Uginet, P. De Stefano et al.
· Neurology(R) neuroimmunology... · 0 citations